ONCY Stock Analysis: Buy, Sell, or Hold?

ONCY - Oncolytics Biotech, Inc. Common Shares

Pharmaceutical Preparations
$0.85
0.05 (5.88%) ▲
5d: +1.21%
30d: -2.6%
90d: -14.98%
HOLD
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 06, 2026

Get Alerted When ONCY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: ONCY shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ONCY is currently trading at $0.85, which is considered fair relative to its 30-day fair value range of $0.80 to $0.93.

Technical Outlook: Technically, ONCY is in a downtrend. Immediate support is located at $0.80, while resistance sits at $1.18. The stock is showing strong short-term momentum, up 5.9% recently.

Market Sentiment: ONCY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.01 (+489.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.80 - $0.93
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 55.3%

All Signals

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+5.9%)
  • BULLISH: Trading 489.1% below Wall St target ($5.01)

Trading Range Analysis

30-Day Trading Range $0.80 - $0.93
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $0.80
Resistance Level $1.18
Current Trend Downtrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.54
Wall Street Target $5.01 (+489.1%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 16, 2026 12:23 AM ET
Data refreshes hourly during market hours. Next update: 1:23 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
14
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jared Kelly BUY 5050 shares 2026-03-12
James T Parsons BUY 10000 shares 2026-03-11
Allison Hagerman BUY 10000 shares 2026-02-12

Unlock Insider Activity

See real-time buying/selling by company executives for ONCY.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$58 55 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 57 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$119 57 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$93 53 HOLD
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$256 59 HOLD

More Analysis for ONCY

ONCY Technical Chart ONCY Price Prediction ONCY Earnings Date ONCY Investment Advisor ONCY Fair Price Analyzer ONCY Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals